Latest Regulatory Approvals News

Page 179 of 324
Syntara Limited has reported positive final data from its Phase 2a trial of amsulostat in myelofibrosis, demonstrating significant symptom relief and spleen volume reduction with a favorable safety profile. These results pave the way for advancing clinical development and partnership discussions.
Ada Torres
Ada Torres
30 Sept 2025
Orthocell has appointed its first Canadian distributor for Remplir, its innovative nerve repair device, ahead of an official launch at a major surgical conference in Vancouver. The move marks a significant step in expanding the product’s international footprint.
Ada Torres
Ada Torres
30 Sept 2025
Australian Vanadium Limited has locked in a US$10 million secured loan from major shareholder RCF to advance its flagship vanadium project and prepare for a significant government battery storage tender.
Maxwell Dee
Maxwell Dee
30 Sept 2025
Southern Cross Media Group and Seven West Media have agreed to merge in an all-scrip deal, creating a dominant integrated TV, audio, and digital platform across Australia. The merger aims to unlock significant cost synergies and expand audience reach across metropolitan and regional markets.
Elise Vega
Elise Vega
30 Sept 2025
Seven West Media and Southern Cross Media have announced a proposed all-scrip merger to create a leading integrated media company spanning TV, audio, digital, and publishing platforms across Australia.
Elise Vega
Elise Vega
30 Sept 2025
Southern Cross Media Group and Seven West Media have agreed to merge, creating a dominant integrated TV, audio, and digital platform in Australia. The deal promises significant cost synergies and shareholder value accretion, pending regulatory and shareholder approvals.
Elise Vega
Elise Vega
30 Sept 2025
Seven West Media and Southern Cross Media have agreed to merge, creating a dominant integrated media company with extensive reach across TV, audio, and digital platforms in Australia. The merger promises significant cost synergies and enhanced shareholder value, pending regulatory and shareholder approvals.
Elise Vega
Elise Vega
30 Sept 2025
Dimerix Limited’s lead drug candidate DMX-200 has been granted Orphan Drug Designation in Japan for treating Focal Segmental Glomerulosclerosis (FSGS), enhancing its regulatory and commercial prospects in a key market.
Ada Torres
Ada Torres
30 Sept 2025
Challenger Gold has secured the final Environmental Impact Assessment amendment for its Hualilán Gold Project, enabling ore haulage and toll milling at the Casposo plant. This milestone unlocks a low-capital pathway to early cash flow while advancing the project’s development.
Maxwell Dee
Maxwell Dee
30 Sept 2025
Power Minerals confirms a high-grade carbonatite hard rock intrusion at its Santa Anna Rare Earth Elements Project in Brazil, with promising grades and ongoing drilling aimed at defining a maiden resource estimate.
Maxwell Dee
Maxwell Dee
30 Sept 2025
Aquirian Limited reports a 16.7% revenue increase alongside key operational advances at its Wubin facility and new leadership appointments, signaling strong momentum in mining services and technology.
Victor Sage
Victor Sage
30 Sept 2025
TPC Consolidated and Wollar Solar Holding have agreed to extend key deadlines in their acquisition scheme as they await crucial FIRB approval, pushing the timeline into early 2026.
Maxwell Dee
Maxwell Dee
30 Sept 2025